Don’t miss our upcoming live webinars!
Sign up
Maximize your chances of pregnancy without losing good embryos
August 12, 2021
1:00PM (EST)
Although a good quality embryo is an important starting point, it is also important to transfer the embryo into a uterus that is ready to receive the embryo. In this webinar, you will understand the keys to endometrial receptivity.
TIFFANY STANKEWICZ
Previous Webinars:
View Recording
Maximize your chances of pregnancy without losing good embryos
May 6, 2021
1:00PM (EST)
Although a good quality embryo is an important starting point, it is also important to transfer the embryo into a uterus that is ready to receive the embryo. In this webinar, you will understand the keys to endometrial receptivity.
TIFFANY STANKEWICZ
Sign up
The PGT-A experience with Igenomix
September 2, 2021
1:00PM (EST)
An advance insight for patients to learn more about
PGT-A technology and experience from our VP of
Clinical Genetic Testing. Helping you have a successful pregnancy and a healthy baby by selecting chromosomally normal embryos.
Dr. Alyssa Snider
View Recording
The PGT-A experience with Igenomix
June 2, 2021
1:00PM (EST)
An advance insight for patients to learn more about
PGT-A technology and experience from our VP of
Clinical Genetic Testing. Helping you have a successful pregnancy and a healthy baby by selecting chromosomally normal embryos.
Dr. Alyssa Snider
Sign up
What’s on the horizon for embryo testing?
EMBRACE
October 7, 2021
1:00PM (EST)
Curious to know what the future holds for genetic testing of embryos? EMBRACE is a non-invasive test for prioritizing embryo transfer that avoids invasive embryo biopsy, thereby potentially increasing accessibility for a wider patient population. Learn more about EMBRACE with our VP of Clinical Genetic Testing.
Dr. Alyssa Snider
View Recording
What’s on the horizon for embryo testing?
EMBRACE
July 1, 2021
1:00PM (EST)
Curious to know what the future holds for genetic testing of embryos? EMBRACE is a non-invasive test for prioritizing embryo transfer that avoids invasive embryo biopsy, thereby potentially increasing accessibility for a wider patient population. Learn more about EMBRACE with our VP of Clinical Genetic Testing.
